Literature DB >> 11278368

HIV-1 Tat protein interacts with mammalian capping enzyme and stimulates capping of TAR RNA.

Y L Chiu1, E Coronel, C K Ho, S Shuman, T M Rana.   

Abstract

HIV gene expression is subject to a transcriptional checkpoint, whereby negative transcription elongation factors induce an elongation block that is overcome by HIV Tat protein in conjunction with P-TEFb. P-TEFb is a cyclin-dependent kinase that catalyzes Tat-dependent phosphorylation of Ser-5 of the Pol II C-terminal domain (CTD). Ser-5 phosphorylation confers on the CTD the ability to recruit the mammalian mRNA capping enzyme (Mce1) and stimulate its guanylyltransferase activity. Here we show that Tat spearheads a second and novel pathway of capping enzyme recruitment and activation via a direct physical interaction between the C-terminal domain of Tat and Mce1. Tat stimulates the guanylyltransferase and triphosphatase activities of Mce1 and thereby enhances the otherwise low efficiency of cap formation on a TAR stem-loop RNA. Our findings suggest that multiple mechanisms exist for coupling transcription elongation and mRNA processing.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11278368     DOI: 10.1074/jbc.M007901200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

1.  The Tat/TAR-dependent phosphorylation of RNA polymerase II C-terminal domain stimulates cotranscriptional capping of HIV-1 mRNA.

Authors:  Meisheng Zhou; Longwen Deng; Fatah Kashanchi; John N Brady; Aaron J Shatkin; Ajit Kumar
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-20       Impact factor: 11.205

2.  The cytoplasmic fate of an mRNP is determined cotranscriptionally: exception or rule?

Authors:  Tatjana Trcek; Robert H Singer
Journal:  Genes Dev       Date:  2010-09-01       Impact factor: 11.361

3.  Kick-sTARting HIV-1 transcription elongation by 7SK snRNP deporTATion.

Authors:  Matjaz Barboric; Tina Lenasi
Journal:  Nat Struct Mol Biol       Date:  2010-08       Impact factor: 15.369

4.  Structural basis for transcriptional start site control of HIV-1 RNA fate.

Authors:  Joshua D Brown; Siarhei Kharytonchyk; Issac Chaudry; Aishwarya S Iyer; Hannah Carter; Ghazal Becker; Yash Desai; Lindsay Glang; Seung H Choi; Karndeep Singh; Michael W Lopresti; Matthew Orellana; Tatiana Rodriguez; Ubiomo Oboh; Jana Hijji; Frances Grace Ghinger; Kailan Stewart; Dillion Francis; Bryce Edwards; Patrick Chen; David A Case; Alice Telesnitsky; Michael F Summers
Journal:  Science       Date:  2020-04-24       Impact factor: 47.728

5.  Construction of a doxycycline-dependent simian immunodeficiency virus reveals a nontranscriptional function of tat in viral replication.

Authors:  Atze T Das; Bep Klaver; Alex Harwig; Monique Vink; Marcel Ooms; Mireille Centlivre; Ben Berkhout
Journal:  J Virol       Date:  2007-08-01       Impact factor: 5.103

6.  The HIV-1 Tat protein has a versatile role in activating viral transcription.

Authors:  Atze T Das; Alex Harwig; Ben Berkhout
Journal:  J Virol       Date:  2011-07-13       Impact factor: 5.103

7.  A mutant tat protein inhibits HIV-1 reverse transcription by targeting the reverse transcription complex.

Authors:  Min-Hsuan Lin; Ann Apolloni; Vincent Cutillas; Haran Sivakumaran; Sally Martin; Dongsheng Li; Ting Wei; Rui Wang; Hongping Jin; Kirsten Spann; David Harrich
Journal:  J Virol       Date:  2015-02-11       Impact factor: 5.103

8.  Trimethylguanosine capping selectively promotes expression of Rev-dependent HIV-1 RNAs.

Authors:  Venkat S R K Yedavalli; Kuan-Teh Jeang
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-02       Impact factor: 11.205

9.  Methamphetamine augment HIV-1 Tat mediated memory deficits by altering the expression of synaptic proteins and neurotrophic factors.

Authors:  Anantha Ram Nookala; Daniel C Schwartz; Nitish S Chaudhari; Alexy Glazyrin; Edward B Stephens; Nancy E J Berman; Anil Kumar
Journal:  Brain Behav Immun       Date:  2018-05-02       Impact factor: 7.217

10.  Feline immunodeficiency virus OrfA alters gene expression of splicing factors and proteasome-ubiquitination proteins.

Authors:  Magnus Sundstrom; Udayan Chatterji; Lana Schaffer; Sohela de Rozières; John H Elder
Journal:  Virology       Date:  2007-10-25       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.